Cite
Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
MLA
Byrne, Dana D., et al. “Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.” Clinical Infectious Diseases, vol. 65, no. 9, Nov. 2017, pp. 1542–50. EBSCOhost, https://doi.org/10.1093/cid/cix564.
APA
Byrne, D. D., Tate, J. P., Forde, K. A., Lim, J. K., Goetz, M. B., Rimland, D., Rodriguez-Barradas, M. C., Butt, A. A., Gibert, C. L., Brown, S. T., Bedimo, R., Freiberg, M. S., Justice, A. C., Kostman, J. R., Roy, J. A., & Lo Re III, V. (2017). Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status. Clinical Infectious Diseases, 65(9), 1542–1550. https://doi.org/10.1093/cid/cix564
Chicago
Byrne, Dana D., Janet P. Tate, Kimberly A. Forde, Joseph K. Lim, Matthew Bidwell Goetz, David Rimland, Maria C. Rodriguez-Barradas, et al. 2017. “Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.” Clinical Infectious Diseases 65 (9): 1542–50. doi:10.1093/cid/cix564.